+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intersect ENT Inc. - logo

Intersect ENT is a medical company that focuses on producing treatments for ears, nose and throat conditions through innovative research. It offers PROPEL and PROPEL mini drug releasing implants for patients undergoing sinus surgery to treat chronic sinusitis. They were formerly known as Sinexus, Inc. but changed their name to Intersect ENT in 2009. They were founded in 2003, and their headquarters are located in Menlo Park, California. They develop a pipeline of steroid releasing implants designed to provide ENT physicians with options to treat patients.

From
Global Sinus Dilation Devices Market Outlook 2028 - Product Thumbnail Image

Global Sinus Dilation Devices Market Outlook 2028

  • Report
  • March 2021
  • 104 pages
From
From
From
Global Sinus Dilation Devices Market 2020-2024 - Product Thumbnail Image

Global Sinus Dilation Devices Market 2020-2024

  • Report
  • March 2020
  • 120 pages
From
From
From
Global Nasal Implants Market 2019-2023 - Product Thumbnail Image

Global Nasal Implants Market 2019-2023

  • Report
  • March 2019
  • 112 pages
From
From
From
From
Loading Indicator
adroll